Pittenger & Anderson Inc’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-15
Closed -$1.3K 553
2026
Q1
$1.3K Sell
15
-100
-87% -$9.58K ﹤0.01% 483
2025
Q4
$11K Hold
115
﹤0.01% 405
2025
Q3
$11K Buy
115
+15
+15% +$1.38K ﹤0.01% 362
2025
Q2
$8.72K Hold
100
﹤0.01% 362
2025
Q1
$8.99K Hold
100
﹤0.01% 356
2024
Q4
$7.99K Hold
100
﹤0.01% 371
2024
Q3
$9K Buy
+100
New +$8.41K ﹤0.01% 379
2023
Q3
Sell
-85
Closed -$7.49K 449
2023
Q2
$7.49K Hold
85
﹤0.01% 374
2023
Q1
$6.85K Sell
85
-36,156
-100% -$2.95M ﹤0.01% 371
2022
Q4
$2.82M Sell
36,241
-1,660
-4% -$135K 0.15% 126
2022
Q3
$3.06M Buy
37,901
+740
+2% +$66.5K 0.18% 116
2022
Q2
$3.33M Buy
37,161
+141
+0.4% +$14.3K 0.19% 111
2022
Q1
$4.11M Sell
37,020
-1,096
-3% -$116K 0.2% 110
2021
Q4
$3.94M Buy
38,116
+2,748
+8% +$318K 0.18% 111
2021
Q3
$4.43M Buy
35,368
+1,323
+4% +$171K 0.22% 101
2021
Q2
$4.23M Buy
34,045
+75
+0.2% +$9.42K 0.22% 101
2021
Q1
$4.01M Buy
33,970
+1,095
+3% +$128K 0.22% 102
2020
Q4
$3.85M Buy
32,875
+995
+3% +$110K 0.22% 105
2020
Q3
$3.31M Buy
31,880
+1,395
+5% +$140K 0.21% 103
2020
Q2
$2.79M Buy
30,485
+1,675
+6% +$161K 0.2% 108
2020
Q1
$2.6M Sell
28,810
-1,075
-4% -$114K 0.22% 103
2019
Q4
$3.39M Buy
29,885
+875
+3% +$96K 0.23% 111
2019
Q3
$3.15M Buy
29,010
+120
+0.4% +$12.5K 0.23% 110
2019
Q2
$2.81M Buy
28,890
+130
+0.5% +$11.9K 0.21% 121
2019
Q1
$2.62M Hold
28,760
0.2% 118
2018
Q4
$2.62M Buy
28,760
+135
+0.5% +$12.6K 0.24% 107
2018
Q3
$2.82M Hold
28,625
0.22% 116
2018
Q2
$2.45M Sell
28,625
-100
-0.3% -$8.35K 0.21% 119
2018
Q1
$2.3M Buy
28,725
+1,563
+6% +$129K 0.2% 120
2017
Q4
$2.19M Buy
27,162
+2,367
+10% +$190K 0.19% 127
2017
Q3
$1.93M Buy
24,795
+83
+0.3% +$6.89K 0.17% 127
2017
Q2
$2.19M Sell
24,712
-3
-0% -$253 0.21% 116
2017
Q1
$1.99M Sell
24,715
-284
-1% -$22.2K 0.2% 122
2016
Q4
$1.78M Sell
24,999
-580
-2% -$45.6K 0.19% 123
2016
Q3
$2.21M Sell
25,579
-105
-0.4% -$9.15K 0.25% 104
2016
Q2
$2.23M Sell
25,684
-165
-0.6% -$13.3K 0.25% 103
2016
Q1
$1.94M Buy
25,849
+515
+2% +$38.8K 0.23% 110
2015
Q4
$1.95M Buy
25,334
+2,765
+12% +$208K 0.24% 110
2015
Q3
$1.53M Sell
22,569
-195
-0.9% -$14.4K 0.2% 123
2015
Q2
$1.69M Buy
22,764
+490
+2% +$37.4K 0.22% 120
2015
Q1
$1.74M Buy
22,274
+3,891
+21% +$295K 0.22% 113
2014
Q4
$1.33M Buy
18,383
+260
+1% +$18.1K 0.18% 130
2014
Q3
$1.12M Buy
18,123
+475
+3% +$30.2K 0.16% 125
2014
Q2
$1.13M Buy
17,648
+583
+3% +$35.4K 0.17% 124
2014
Q1
$1.05M Buy
17,065
+1,920
+13% +$112K 0.15% 152
2013
Q4
$869K Sell
15,145
-222
-1% -$12.6K 0.12% 161
2013
Q3
$818K Buy
15,367
+2,155
+16% +$116K 0.13% 153
2013
Q2
$680K Buy
+13,212
New +$653K 0.12% 158

Other funds holding MDT

Pittenger & Anderson Inc's MDT Position: Q2 2026 in Review

Pittenger & Anderson Inc sold out of Medtronic (MDT) in Q2 2026, closing a stake of 15 shares — an estimated $1.3K sold.

Pittenger & Anderson Inc first reported a position in MDT in Q2 2013 and held it in 48 quarters. The position peaked at $4.43M in Q3 2021. 2,123 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Pittenger & Anderson Inc reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
  • Pittenger & Anderson Inc sold 15 Medtronic shares in Q2 2026, an estimated $1.3K.
  • Pittenger & Anderson Inc first reported a position in Medtronic in Q2 2013 and held it in 48 quarters.
  • Pittenger & Anderson Inc's Medtronic position peaked at $4.43M in Q3 2021.
  • 2,123 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Pittenger & Anderson Inc's 13F filing for Q2 2026, filed 27 Jul 2026.